Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Array biopharma patent larotrectinib synthesis?Cabotegravir approval date?How much is clomid without insurance?How often should lurbinectedin's side effects be checked?Icosapent ethyl patente?
See the DrugPatentWatch profile for mydayis
Mydayis is a brand of amphetamine/dextroamphetamine extended-release for ADHD. A “generic Mydayis” would be any FDA-approved generic version with the same active ingredients and extended-release formulation—typically called amphetamine/dextroamphetamine extended-release capsules. Because generic drug labeling uses the active-ingredient name rather than a single substitute brand name, the generic is commonly referred to by that description rather than a different brand.
There usually is no single separate brand name that every prescription calls “generic Mydayis.” When a pharmacy substitutes, it’s generally the generic active-ingredient name (amphetamine/dextroamphetamine ER), plus the manufacturer’s product labeling.
Ask for: “amphetamine/dextroamphetamine extended-release capsules (generic to Mydayis), in the same strength.” If you share your Mydayis strength (e.g., 12.5 mg, 25 mg, 37.5 mg, 50 mg, etc.), I can help you narrow down what the generic should be called.
No source information was provided here that confirms an exact product/generic label name for Mydayis in your market.
Other Questions About Mydayis :